Strategies used by human immunodeficiency virus that allow persistent viral replication.
about
Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.AAV-Delivered Antibody Mediates Significant Protective Effects against SIVmac239 Challenge in the Absence of Neutralizing ActivityInhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies.Net positive charge of HIV-1 CRF01_AE V3 sequence regulates viral sensitivity to humoral immunity.Epithelial stem cells as mucosal antigen-delivering cells: A novel AIDS vaccine approach.Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus.In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail.Quintuple deglycosylation mutant of simian immunodeficiency virus SIVmac239 in rhesus macaques: robust primary replication, tightly contained chronic infection, and elicitation of potent immunity against the parental wild-type strain.CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivoRole of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatmentNovel, live attenuated simian immunodeficiency virus constructs containing major deletions in leader RNA sequencesHIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activationImportance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus.Effect of humoral immune responses on controlling viremia during primary infection of rhesus monkeys with simian immunodeficiency virusnef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes.Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levelsVaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus.Ability of herpes simplex virus vectors to boost immune responses to DNA vectors and to protect against challenge by simian immunodeficiency virusIn vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assaysAntibody-mediated protection against cytotoxic T-cell escape in coronavirus-induced demyelinationPotent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo.Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodiesEfficient class I major histocompatibility complex down-regulation by simian immunodeficiency virus Nef is associated with a strong selective advantage in infected rhesus macaques.Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDSNef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism.Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection.A recombinant herpesviral vector containing a near-full-length SIVmac239 genome produces SIV particles and elicits immune responses to all nine SIV gene products.
P2860
Q24529180-9BECA844-620F-4484-B3F0-2A2677A9C623Q27318266-6FB5820F-7C99-4339-B6D7-65A57F8D5F14Q31115718-3A60AE32-4939-4A4F-8460-B6256E3D5D83Q33369086-4CAF06D5-303D-4016-8323-D8932752C9DCQ33657468-352ABC7C-AC6B-4AF0-A7F2-5FD58DAF1AC7Q33810277-A56F5ED8-B656-41CD-B335-89D5202E1D2EQ33834814-65B3EDE9-0548-4EC7-8524-4B7642B5C089Q33839044-29AA6980-36C2-4D89-911F-62EC1696A6EFQ33847490-1016DC8E-58A1-4295-A191-FBC5380624AEQ33847673-76D44E1A-BB74-4976-89E5-87A33B63C921Q33865700-AEBACAA8-3E4A-4321-8C8B-D3C92C074C67Q33892217-EAE1C085-B25B-476F-89AF-62B7462DF4C6Q34462440-AD54792D-8286-4099-97AF-45C5C0CC3AADQ34468698-4F0347B9-7A3B-488A-8BA4-F37868A6A2E0Q34782209-350EDEC0-9EAD-4BF0-A11D-5ED36B704C93Q34910224-B4E97C4B-03E0-4692-8567-34F2AB9649C7Q35531553-1FEA78BC-E048-4B91-9DDE-D34B8778FD9DQ35675044-9DF88E24-9ACF-4F9D-B19B-76CB0276F33FQ35942568-0F255F77-6F2E-4D16-BA7D-6D62C1ED717DQ36363866-B97CC921-2A4D-497A-8E70-163A1D8F07B1Q36890391-7574623D-A15A-4C64-842C-C93D45C58B89Q36898925-BF911DEA-D833-48DA-9161-62FAC9247D8AQ36978847-43DFB218-8CD5-46FA-8740-4AEC46CEB10DQ37621530-E7D48DCA-BEBC-4A3F-90E5-10CFF7082C7DQ39604845-4987E129-E0DA-490E-9D3D-FB478B28E24AQ39605895-1036FF7A-6D05-4331-99CE-714D9D7A4AEDQ39753053-6B7F7871-2723-465B-AB95-FCD7B29DF376Q45734462-D0188477-48BB-4338-A02C-2ADC6CD2AE26Q55444789-5A9C4368-03F9-47BF-B067-659B862548FC
P2860
Strategies used by human immunodeficiency virus that allow persistent viral replication.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Strategies used by human immunodeficiency virus that allow persistent viral replication.
@ast
Strategies used by human immunodeficiency virus that allow persistent viral replication.
@en
type
label
Strategies used by human immunodeficiency virus that allow persistent viral replication.
@ast
Strategies used by human immunodeficiency virus that allow persistent viral replication.
@en
prefLabel
Strategies used by human immunodeficiency virus that allow persistent viral replication.
@ast
Strategies used by human immunodeficiency virus that allow persistent viral replication.
@en
P2860
P356
P1433
P1476
Strategies used by human immunodeficiency virus that allow persistent viral replication.
@en
P2093
Desrosiers RC
P2860
P2888
P304
P356
10.1038/10439
P407
P577
1999-07-01T00:00:00Z